The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells
Open accessAbstract
Select changes in microRNA (miRNA) expression correlate with estrogen receptor alpha (ER alpha) expression in breast tumors. miR-21 is higher in ER alpha positive than negative tumors, but no one has examined how estradiol (E(2)) regulates miR-21 in breast cancer cells. Here we report that E(2) inhibits miR-21 expression in MCF-7 human breast cancer cells. The E(2)-induced reduction in miR-21 was inhibited by 4-hydroxytamoxifen (4-OHT), ICI 182 780 (Faslodex), and siRNA ER alpha indicating that the suppression is ER alpha-mediated. ER alpha and ER beta agonists PPT and DPN inhibited and 4-OHT increased miR-21 expression. E(2) increased luciferase activity from reporters containing the miR-21 recognition elements from the 3'-UTRs of miR-21 target genes, corroborating that E(2) represses miR-21 expression resulting in a loss of target gene suppression. The E(2)-mediated decrease in miR-21 correlated with increased protein expression of endogenous miR-21-targets Pdcd4, PTEN and Bcl-2. siRNA knockdown of ER alpha blocked the E(2)-induced increase in Pdcd4, PTEN and Bcl-2. Transfection of MCF-7 cells with antisense (AS) to miR-21 mimicked the E(2)-induced increase in Pdcd4, PTEN and Bcl-2. These results are the first to demonstrate that E(2) represses the expression of an oncogenic miRNA, miR-21, by activating estrogen receptor in MCF-7 cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Pan, Q., Luo, X., Toloubeydokhti, T., & Chegini, N. (2007) · Molecular Human Reproduction · doi:10.1093/molehr/gam063 · Cited by 261
RetractedA microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,485
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Iorio, M. V., Ferracin, M., Liu, C.-G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1783 · Cited by 4,053
MicroRNA Targeting Specificity in Mammals: Determinants beyond Seed Pairing
Grimson, A., Farh, K. K.-H., Johnston, W. K., Garrett-Engele, P., Lim, L. P., & Bartel, D. P. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.06.017 · Cited by 3,766
RAS Is Regulated by the let-7 MicroRNA Family
Johnson, S. M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., & Slack, F. J. (2005) · Cell · doi:10.1016/j.cell.2005.01.014 · Cited by 3,656
Switching from Repression to Activation: MicroRNAs Can Up-Regulate Translation
Vasudevan, S., Tong, Y., & Steitz, J. A. (2007) · Science · doi:10.1126/science.1149460 · Cited by 2,822
MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer
Meng, F., Henson, R., Wehbe–Janek, H., Ghoshal, K., Jacob, S. T., & Patel, T. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.022 · Cited by 2,773
MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells
Chan, J. A., Krichevsky, A. M., & Kosik, K. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0137 · Cited by 2,557
Nuclear Receptor Coregulators: Cellular and Molecular Biology*
McKenna, N. J., Lanz, R. B., & O’Malley, B. W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0366 · Cited by 1,911
Asangani, I. A., Rasheed, S. A. K., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S., & Allgayer, H. (2008) · Oncogene · doi:10.1038/sj.onc.1210856 · Cited by 1,882
CAI, X., HAGEDORN, C. H., & CULLEN, B. R. (2004) · RNA · doi:10.1261/rna.7135204 · Cited by 1,872
Si, M.-L., Zhu, S., Wu, H., Lu, Z., Wu, F., & Mo, Y.-Y. (2007) · Oncogene · doi:10.1038/sj.onc.1210083 · Cited by 1,600
Hayashita, Y., Osada, H., Tatematsu, Y., Yamada, H., Yanagisawa, K., Tomida, S., Yatabe, Y., Kawahara, K., Sekido, Y., & Takahashi, T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2352 · Cited by 1,511
Genome-wide analysis of estrogen receptor binding sites
Carroll, J. S., Meyer, C. A., Song, J., Li, W., Geistlinger, T. R., Eeckhoute, J., Brodsky, A. S., Keeton, E. K., Fertuck, K. C., Hall, G. F., et al. (2006) · Nature Genetics · doi:10.1038/ng1901 · Cited by 1,377
Estrogen receptors and human disease
Deroo, B. J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27987 · Cited by 1,320
Ribo-gnome: The Big World of Small RNAs
Zamore, P. D., & Haley, B. (2005) · Science · doi:10.1126/science.1111444 · Cited by 1,288
The let-7 MicroRNA Represses Cell Proliferation Pathways in Human Cells
Johnson, C. D., Esquela-Kerscher, A., Stefani, G., Byrom, M., Kelnar, K., Ovcharenko, D., Wilson, M., Wang, X., Shelton, J., Shingara, J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1083 · Cited by 1,224
Frankel, L. B., Christoffersen, N. R., Jacobsen, A., Lindow, M., Krogh, A., & Lund, A. H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707224200 · Cited by 1,141
microRNAs exhibit high frequency genomic alterations in human cancer
Zhang, L., Huang, J., Yang, N., Greshock, J., Megraw, M. S., Giannakakis, A., Liang, S., Naylor, T. L., Barchetti, A., Ward, M. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508889103 · Cited by 1,031
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype
Blenkiron, C., Goldstein, L. D., Thorne, N. P., Spiteri, I., Chin, S.-F., Dunning, M. J., Barbosa-Morais, N. L., Teschendorff, A. E., Green, A. R., Ellis, I. O., et al. (2007) · Genome Biology · doi:10.1186/gb-2007-8-10-r214 · Cited by 948
Genetic Unmasking of an Epigenetically Silenced microRNA in Human Cancer Cells
Lujambio, A., Ropero, S., Ballestar, E., Fraga, M. F., Cerrato, C., Setién, F., Casado, S., Suarez-Gauthier, A., Sanchez-Cespedes, M., Gitt, A., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4218 · Cited by 939
Extensive post-transcriptional regulation of microRNAs and its implications for cancer
Thomson, J. M., Newman, M., Parker, J. S., Morin-Kensicki, E. M., Wright, T., & Hammond, S. M. (2006) · Genes & Development · doi:10.1101/gad.1444406 · Cited by 877
Frasor, J., Danes, J. M., Komm, B., Chang, K. C. N., Lyttle, C. R., & Katzenellenbogen, B. S. (2003) · Endocrinology · doi:10.1210/en.2003-0567 · Cited by 876
Gramantieri, L., Ferracin, M., Fornari, F., Veronese, A., Sabbioni, S., Liu, C.-G., Calin, G. A., Giovannini, C., Ferrazzi, E., Grazi, G. L., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4607 · Cited by 813
Mattie, M. D., Benz, C. C., Bowers, J., Sensinger, K., Wong, L., Scott, G. K., Fedele, V., Ginzinger, D. G., Getts, R. C., & Haqq, C. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-24 · Cited by 787
MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1
Miller, T. E., Ghoshal, K., Ramaswamy, B., Roy, S., Datta, J., Shapiro, C. L., Jacob, S., & Majumder, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804612200 · Cited by 749
Gaur, A., Jewell, D. A., Liang, Y., Ridzon, D., Moore, J. H., Chen, C., Ambros, V. R., & Israel, M. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2698 · Cited by 727
MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene
Lu, Z., Liu, M., Stribinskis, V, Klinge, C. M., Ramos, K. S., Colburn, N. H., & Li, Y. (2008) · Oncogene · doi:10.1038/onc.2008.72 · Cited by 711
Self-citationIntegration of the extranuclear and nuclear actions of estrogen
Levin, E. R. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0390 · Cited by 708
Estrogen Signaling Multiple Pathways to Impact Gene Transcription
Marino, M., Galluzzo, P., & Ascenzi, P. (2006) · Current Genomics · doi:10.2174/138920206779315737 · Cited by 619
Altered MicroRNA Expression Confined to Specific Epithelial Cell Subpopulations in Breast Cancer
Sempere, L. F., Christensen, M., Silahtaroglu, A., Bak, M., Heath, C. V., Schwartz, G., Wells, W., Kauppinen, S., & Cole, C. N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-5019 · Cited by 574
Genomic analysis of human microRNA transcripts
Saini, H. K., Griffiths-Jones, S., & Enright, A. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703890104 · Cited by 554
Ström, A., Hartman, J., Foster, J. S., Kietz, S., Wimalasena, J., & Gustafsson, J.-Å. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308319100 · Cited by 534
Mir-17-5p Regulates Breast Cancer Cell Proliferation by Inhibiting Translation of AIB1 mRNA
Hossain, A., Kuo, M. T., & Saunders, G. F. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00242-06 · Cited by 511
Real-time expression profiling of microRNA precursors in human cancer cell lines
Jiang, J. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki863 · Cited by 501
Rapid Alteration of MicroRNA Levels by Histone Deacetylase Inhibition
Scott, G. K., Mattie, M. D., Berger, C. E., Benz, S. C., & Benz, C. C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3632 · Cited by 492
Adams, B. D., Furneaux, H., & White, B. A. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0022 · Cited by 478
miR-21 Gene Expression Triggered by AP-1 Is Sustained through a Double-Negative Feedback Mechanism
Fujita, S., Ito, T., Mizutani, T., Minoguchi, S., Yamamichi, N., Sakurai, K., & Iba, H. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.03.015 · Cited by 433
Wijayaratne, A. L., & McDonnell, D. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101097200 · Cited by 427
Hammond, S. M. (2006) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.12.005 · Cited by 406
Selective Estrogen Receptor Modulators
Frasor, J., Stossi, F., Danes, J. M., Komm, B., Lyttle, C. R., & Katzenellenbogen, B. S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3326 · Cited by 395
Hurteau, G. J., Carlson, J. A., Spivack, S. D., & Brock, G. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1058 · Cited by 390
Safe, S., & Kim, K. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0103 · Cited by 368
Harrington, W. R., Sheng, S., Barnett, D. H., Petz, L. N., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(03)00255-7 · Cited by 300
Principles of micro-RNA production and maturation
Zeng, Y. (2006) · Oncogene · doi:10.1038/sj.onc.1209908 · Cited by 267
Dong, L., Wang, W., Wang, F., Stoner, M., Reed, J. C., Harigai, M., Samudio, I., Kladde, M. P., Vyhlidal, C., & Safe, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32099 · Cited by 259
Helguero, L. A., Faulds, M. H., Gustafsson, J.-Å., & Haldosén, L.-A. (2005) · Oncogene · doi:10.1038/sj.onc.1208807 · Cited by 250
Comparative Analyses of Mechanistic Differences Among Antiestrogens1
Wijayaratne, A. L., Nagel, S. C., Paige, L. A., Christensen, D. J., Norris, J. D., Fowlkes, D. M., & McDonnell, D. P. (1999) · Endocrinology · doi:10.1210/endo.140.12.7164 · Cited by 244
Mattingly, K. A., Ivanova, M. M., Riggs, K. A., Wickramasinghe, N. S., Barch, M. J., & Klinge, C. M. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0029 · Cited by 243
Self-citationMicroRNAs in biological processes and carcinogenesis
Osada, H., & Takahashi, T. (2007) · Carcinogenesis · doi:10.1093/carcin/bgl185 · Cited by 240
MicroRNA Expression and Regulation in Mouse Uterus during Embryo Implantation
Hu, S.-J., Ren, G., Liu, J.-L., Zhao, Z.-A., Yu, Y.-S., Su, R.-W., Ma, X.-H., Ni, H., Lei, W., & Yang, Z.-M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800406200 · Cited by 207
Enhanced NFκB and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer
Zhou, Y., Yau, C., Gray, J. W., Chew, K., Dairkee, S. H., Moore, D. H., Eppenberger, U., Eppenberger-Castori, S., & Benz, C. C. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-59 · Cited by 203
Matthews, J., Wihlén, B., Tujague, M., Wan, J., Ström, A., & Gustafsson, J.-Å. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0140 · Cited by 179
Diederichs, S., & Haber, D. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0537 · Cited by 176
Distinct Roles of Unliganded and Liganded Estrogen Receptors in Transcriptional Repression
Cvoro, A., Tzagarakis-Foster, C., Tatomer, D., Paruthiyil, S., Fox, M. S., & Leitman, D. C. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.014 · Cited by 170
Frasor, J., Chang, E. C., Komm, B., Lin, C.-Y., Vega, V. B., Liu, E. T., Miller, L. D., Smeds, J., Bergh, J., & Katzenellenbogen, B. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4269 · Cited by 162
17‐Beta‐Estradiol induces transformation and tumorigenesis in human breast epithelial cells
Russo, J., Fernandez, S. V., Russo, P. A., Fernbaugh, R., Sheriff, F. S., Lareef, H. M., Garber, J., & Russo, I. H. (2006) · The FASEB Journal · doi:10.1096/fj.05-5399com · Cited by 161
MicroRNAs and endocrine biology
Cuellar, T. L., & McManus, M. T. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06426 · Cited by 160
Mechanisms of primary and secondary estrogen target gene regulation in breast cancer cells
Bourdeau, V., Deschênes, J., Laperrière, D., Aid, M., White, J. H., & Mader, S. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm945 · Cited by 157
Bonofiglio, D., Gabriele, S., Aquila, S., Catalano, S., Gentile, M., Middea, E., Giordano, F., & Andò, S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2453 · Cited by 152
Kwon, Y., García-Bassets, I., Hutt, K. R., Cheng, C. S., Jin, M., Liu, D., Benner, C. W., Wang, D., Ye, Z., Bibikova, M. V., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700715104 · Cited by 147
Why is PTEN an important tumor suppressor?
Li, L., & Ross, A. H. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21593 · Cited by 131
Genetic susceptibility to breast cancer
Bradbury, A. R., & Olopade, O. I. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9038-0 · Cited by 128
Sotoca, A. M., van den Berg, H., Vervoort, J. J. M., van der Saag, P. T., Ström, A., Gustafsson, J.-Α., Rietjens, I. M. C. M., & Murk, A. J. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn141 · Cited by 127
Bcl-2 Gene Family and Related Proteins in Mammary Gland Involution and Breast Cancer
Schorr, K., Li, M., Krajewski, S., Reed, J. C., & Furth, P. A. (1999) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1018773123899 · Cited by 123
Nongenomic actions of low concentration estrogens and xenoestrogens on multiple tissues
Watson, C. S., Alyea, R. A., Jeng, Y., & Kochukov, M. Y. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.05.011 · Cited by 113
Lin, C., Ström, A., Kong, S. L., Kietz, S., Thomsen, J. S., Tee, J. B., Vega, V. B., Miller, L. D., Smeds, J., Bergh, J. C. S., et al. (2007) · Breast Cancer Research · doi:10.1186/bcr1667 · Cited by 107
Gupta, M. S., McDougal, A. J., & Safe, S. H. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(98)00135-6 · Cited by 92
Oestrogen Receptor Function at Classical and Alternative Response Elements
Kushner, P. J., Agard, D. A., Feng, W., Lopez, G. N., Schiau, A., Uht, R. M., Webb, P., & Greene, G. L. (2000) · Novartis Foundation symposium · doi:10.1002/0470870818.ch3 · Cited by 79
Treatment of Postmenopausal Breast Cancer with Selective Estrogen Receptor Modulators (SERMs)
Lewis-Wambi, J. S., & Jordan, V. C. (2006) · Breast Disease · doi:10.3233/bd-2006-24108 · Cited by 75
Neoplastic transformation of human breast epithelial cells by estrogens and chemical carcinogens
Russo, J., Tahin, Q. S., Lareef, M. H., Hu, Y., & Russo, I. H. (2002) · Environmental and Molecular Mutagenesis · doi:10.1002/em.10052 · Cited by 75
Gusev, Y., Schmittgen, T. D., Lerner, M. R., Postier, R. G., & Brackett, D. J. (2007) · BMC Bioinformatics · doi:10.1186/1471-2105-8-s7-s16 · Cited by 72
miRNA genetic alterations in human cancers
Giannakakis, A., Coukos, G., Hatzigeorgiou, A. G., Sandaltzopoulos, R., & Zhang, L. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.9.1375 · Cited by 57
Levenson, A. S., Svoboda, K. M., Pease, K. M., et al. (2002) · PubMed · Cited by 57
Vendrell, J. A., Bièche, I., Desmetz, C., Badia, É., Tozlu, S., Nguyen, C., Nicolas, J., Lidereau, R., & Cohen, P. A. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.00899 · Cited by 53
Loss of tumourigenicity of stably ERβ-transfected MCF-7 breast cancer cells
Behrens, D., Gill, J. H., & Fichtner, I. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.05.012 · Cited by 51
Xie, W., Duan, R., Chen, I., Samudio, I. J., & Safe, S. H. (2000) · Endocrinology · doi:10.1210/endo.141.7.7538 · Cited by 45
New developments in the treatment of postmenopausal breast cancer
Howell, A. (2005) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2005.09.003 · Cited by 26
Erasing MicroRNAs Reveals Their Powerful Punch
Couzin, J. (2007) · Science · doi:10.1126/science.316.5824.530 · Cited by 21
Cited by
Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer
Heneghan, H. M., Miller, N., Lowery, A. J., Sweeney, K. J., Newell, J., & Kerin, M. J. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181cc939f · Cited by 687
Regulation and function of miRNA-21 in health and disease
Kumarswamy, R., Volkmann, I., & Thum, T. (2011) · RNA Biology · doi:10.4161/rna.8.5.16154 · Cited by 607
Zhang, J.-G., Wang, J.-J., Zhao, F., Liu, Q., Jiang, K., & Yang, G.-H. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.02.074 · Cited by 563
The Promising Role of miR-21 as a Cancer Biomarker and Its Importance in RNA-Based Therapeutics
Bautista-Sánchez, D., Arriaga-Canon, C., Pedroza-Torres, A., De La Rosa-Velázquez, I. A., González-Barrios, R., Contreras-Espinosa, L., Montiel-Manríquez, R., Castro-Hernández, C., Fragoso-Ontiveros, V., Álvarez-Gómez, R. M., et al. (2020) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2020.03.003 · Cited by 549
“These results indicate that the estrogen receptor is a negative regulator through the inhibition of DROSHA activity.(78) Consequently, these studies show that the regulation of miR-21 is a complex process that involves transcriptional and posttranscriptional steps along the biogenesis pathway.”
BackgroundDirect Serum Assay for MicroRNA-21 Concentrations in Early and Advanced Breast Cancer
Asaga, S., Kuo, C., Nguyen, T., Terpenning, M., Giuliano, A. E., & Hoon, D. S. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.151845 · Cited by 451
Metadata
- Authors
- Wickramasinghe, N. S., Manavalan, T. T., Dougherty, S. M., Riggs, K. A., Li, Y., & Klinge, C. M.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-03-05
- Volume
- 37
- Issue
- 8
- Pages
- 2584-2595
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2130018512
- Cited by
- 391
- References
- 80
- FWCI
- 10.59
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.